Roberta Pellegrino
A5032559614- Organ Transplantation Techniques and Outcomes
- Liver Disease and Transplantation
- Cardiac, Anesthesia and Surgical Outcomes
- Frailty in Older Adults
- Nutrition and Health in Aging
- Renal Transplantation Outcomes and Treatments
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
- Organ Donation and Transplantation
- Artificial Intelligence in Healthcare and Education
- Liver Disease Diagnosis and Treatment
- Abdominal Surgery and Complications
- Hepatocellular Carcinoma Treatment and Prognosis
- Transplantation: Methods and Outcomes
- Enhanced Recovery After Surgery
Azienda Ospedaliera G. Brotzu
2015-2024
University of Milano-Bicocca
2018
Abstract Background Accurate quality of life (QoL) data and functional results after cancer surgery are lacking for older patients. The international, multicenter Geriatric Oncology Surgical Assessment Functional rEcovery Surgery (GOSAFE) Study compares QoL before identifies predictors decline in QoL. Methods GOSAFE prospectively collected major elective on adults (≥70 years). Frailty assessment was performed postoperative outcomes recorded (30, 90, 180 days postoperatively) together with by...
The GOSAFE study evaluates risk factors for failing to achieve good quality of life (QoL) and functional recovery (FR) in older patients undergoing surgery colon rectal cancer.
Total laparoscopic right hemicolectomy is a procedure that involves an intracorporeal anastomosis. This approach may reduce tissue injury resulting in significant lower surgical stress response (SSR) compared with the same performed extracorporeal The purpose of this study was to compare SSR level between 2 groups patients undergoing or From June 2015 December 2016, 60 were enrolled and randomized. Interleukin-6, C-reactive protein, procalcitonin, white blood cell count, cortisol, prolactin,...
Graft-versus-host disease (GVHD) is a rare complication after liver transplantation (LT), with an estimated incidence rate of 0.5% to 2% and mortality as high 75%. The classical target organs GVHD include the intestines, liver, skin. damage these not easy detect for clinician there no widely accepted clinical or laboratory diagnostic tests; result, diagnosis initiation therapy are often delayed. Moreover, without prospective trials reference, evidence guiding limited. This review summarized...